Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Read More…
Industry, Sector and Symbol
Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-161-6676865
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Premaitha Health (LON:NIPT) Frequently Asked Questions
What is Premaitha Health's stock symbol?
Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."
How were Premaitha Health's earnings last quarter?
Premaitha Health PLC (LON:NIPT) issued its earnings results on Friday, December, 29th. The company reported ($2.00) earnings per share for the quarter. The firm had revenue of $2.71 million for the quarter. View Premaitha Health's Earnings History.
Has Premaitha Health been receiving favorable news coverage?
Press coverage about NIPT stock has trended positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Premaitha Health earned a news impact score of 2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Premaitha Health.
Who are some of Premaitha Health's key competitors?
What other stocks do shareholders of Premaitha Health own?
Who are Premaitha Health's key executives?
Premaitha Health's management team includes the folowing people:
- Dr. Stephen Little, Exec. Vice Chairman (Age 61)
- Mr. Barry Hextall, CFO, Sec. & Exec. Director
- Mr. Peter Collins, Chief Bus. Officer & Exec. Director (Age 59)
- Mr. Lyn Fafydd Rees, CEO & Director (Age 45)
- Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 42)
How do I buy shares of Premaitha Health?
Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Premaitha Health's official website?
How can I contact Premaitha Health?
Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The company can be reached via phone at +44-161-6676865.
MarketBeat Community Rating for Premaitha Health (LON NIPT)
MarketBeat's community ratings are surveys of what our community members think about Premaitha Health and other stocks. Vote "Outperform" if you believe NIPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NIPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
